Biological healing accelerator – Japan (License No. 5331482)
Patents Betaglucan

Biological healing accelerator – Japan (License No. 5331482)

Biological healing accelerator – Japan (License No. 5331482) Patent Details Country of RegistrationJapan Patent No.No. 5331482Registration DateAugust 02, 2013Remarks※ Reduction of side effects of anti-cancer drugs Currently, Aureobasidium (black yeast) culture medium (hereafter referred to as “Aureo culture...

Biological healing accelerator – Japan (License No. 5331482)

Country of RegistrationJapan
Patent No.No. 5331482
Registration DateAugust 02, 2013
Remarks※ Reduction of side effects of anti-cancer drugs
Currently, Aureobasidium (black yeast) culture medium (hereafter referred to as “Aureo culture medium”) has been approved in Japan, Europe (UK, France, Germany), China, Hong Kong, Taiwan, and Thailand to reduce the side effects of anticancer drugs and to promote healing of erythema caused by burn wounds.
Next reading

Continue with the research library

Explore source fields, DOI/PMID notes, limitations, and related beta glucan references.

Open Research Hub